Affordable Access

[FEDERAL CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF PNEUMOCONIOSIS].

Authors
  • Artemoval, L V
  • Baskova, N V
  • Burmistrova, T B
  • Buryakinal, E A
  • Buhtiyarov, I V
  • Bushmanov, A Yu
  • Vasilyeva, O S
  • Vlasov, V G
  • Gorblyansky, Y Y
  • Zhabina, S A
  • Zaharinskaya, O N
  • Ismerov, N F
  • Kovalevsky, E V
  • Kuznetsova, G V
  • Kuzmina, L P
  • Kunyaeva, T A
  • Logvinenko, I I
  • Lutsenko, L A
  • Mazitova, N N
  • Obukhova, T Yu
  • And 18 more
Type
Published Article
Journal
Meditsina truda i promyshlennaia ekologiia
Publication Date
Jan 01, 2016
Issue
1
Pages
36–48
Identifiers
PMID: 27048142
Source
Medline
License
Unknown

Abstract

The purpose of development of this clinical practice guidelines was to provide evidence-based protocols that help the practitioner and the patient make the right decision for the health assessment, treatment and prevention of pneumoconiosis. Pneumoconiosis is the interstitial lung disease of occupational origin caused by prolonged inhalation of inorganic dust, characterized by chronic diffuse aseptic inflammation in lung tissue with the development of pulmonary fibrosis. Currently, thereare no treatment that provide a cure pulmonary fibrosis and changes in the dynamics of decline in lung function. Regular, individually tailored treatment should be directed to the pathogenic mechanisms and some clinical symptoms of pneumoconiosis, as well as the prevention of complications. To enhance the effect of pharmacotherapy is recommended to use non-drug therapies that enhance the functionality of the respiratory system.

Report this publication

Statistics

Seen <100 times